Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.
Also called NCT01924065
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 112 participants
- Sponsor
- Registry
-
NCT01924065
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Türkiye
- Registry status
- Completed
Technical summary
Registry record NCT01924065. Randomized; double masking; primary purpose treatment. Start 2013-08 (registry gives no type); primary completion 2017-08 (actual). Results posted on 2024-10-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation
- Acronym
- AFTER-CV
- Condition
- Atrial Fibrillation
- Condition
- Cardioversion
- Condition
- Cerebrovascular Stroke
- Intervention (Procedure)
- Cardioversion
- Intervention (Drug)
- Oral Anticoagulant
- Lead sponsor
- Suleyman Demirel University
Record details
- Record id
cardio:ct-nct01924065- Content hash
38757747bc3dffdfcca38f52a3b7f68162e2a4c8432fa530ff9908409f8cd825